{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:11:31Z","timestamp":1781179891617,"version":"3.54.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To assess the proportion of myeloid-derived suppressor cells (MDSCs), their expression of arginase-1 and programmed cell death ligand 1 (PD-L1) and their relationship with the clinical phenotype of patients with idiopathic inflammatory myopathies (IIMs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We recruited 37 IIM adult patients and 10 healthy donors in Mexico City. We evaluated their clinical features, the proportion of MDSCs and their expression of PD-L1 and arginase-1 by flow cytometry. Polymorphonuclear (PMN)-MDSCs were defined as CD33dim, CD11b+ and CD66b+ while monocytic (M)-MDSCs were CD33+, CD11b+, HLA-DR\u2212 and CD14+. Serum cytokines were analysed with a multiplex assay. We compared the quantitative variables with the Kruskal\u2013Wallis and Mann\u2013Whitney U tests and assessed correlations with Spearman\u2019s \u03c1.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Most patients had dermatomyositis [n\u2009=\u200930 (81.0%)]. IIM patients had a peripheral expansion of PMN-MDSCs and M-MDSCs with an enhanced expression of arginase-1 and PD-L1. Patients with active disease had a decreased percentage {median 1.75% [interquartile range (IQR) 0.31\u20135.50 vs 10.71 [3.16\u201315.58], P\u2009=\u20090.011} of M-MDSCs and a higher absolute number of PD-L1+ M-MDSCs [median 23.21\u2009cells\/mm3 (IQR 11.16\u2013148.9) vs 5.95 (4.66\u2013102.7), P\u2009=\u20090.046] with increased expression of PD-L1 [median 3136 arbitrary units (IQR 2258\u20134992) vs 1961 (1885\u20132335), P\u2009=\u20090.038]. PD-L1 expression in PMN-MDSCs correlated with the visual analogue scale of pulmonary disease activity (r\u2009=\u20090.34, P\u2009=\u20090.040) and damage (r\u2009=\u20090.36, P\u2009=\u20090.031), serum IL-5 (r\u2009=\u20090.55, P\u2009=\u20090.003), IL-6 (r\u2009=\u20090.46, P\u2009=\u20090.003), IL-8 (r\u2009=\u20090.53, P\u2009=\u20090.018), IL-10 (r\u2009=\u20090.48, P\u2009=\u20090.005) and GM-CSF (r\u2009=\u20090.48, P\u2009=\u20090.012). M-MDSCs negatively correlated with the skeletal Myositis Intention to Treat Index (r\u2009=\u2009\u22120.34, P\u2009=\u20090.038) and positively with IL-6 (r\u2009=\u20090.40, P\u2009=\u20090.045).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>MDSCs expressing arginase-1 and PD-L1 are expanded in IIM and correlate with disease activity, damage accrual and serum cytokines.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac374","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:35:23Z","timestamp":1656509723000},"page":"775-784","source":"Crossref","is-referenced-by-count":5,"title":["Peripheral expansion of myeloid-derived suppressor cells is related to disease activity and damage accrual in inflammatory myopathies"],"prefix":"10.1093","volume":"62","author":[{"given":"Jiram","family":"Torres-Ruiz","sequence":"first","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdiel","family":"Absal\u00f3n-Aguilar","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Alberto","family":"Reyes-Islas","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Cassiano-Quezada","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy R","family":"Mej\u00eda-Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Coordinacion de Investigaci\u00f3n Cient\u00edfica, Universidad Nacional Aut\u00f3noma de M\u00e9xico , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"P\u00e9rez-Fragoso","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Maravillas-Montero","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Coordinacion de Investigaci\u00f3n Cient\u00edfica, Universidad Nacional Aut\u00f3noma de M\u00e9xico , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"N\u00fa\u00f1ez-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Ju\u00e1rez-Vega","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Coordinacion de Investigaci\u00f3n Cient\u00edfica, Universidad Nacional Aut\u00f3noma de M\u00e9xico , Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Culebro-Bermejo","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"G\u00f3mez-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"2023020117310832100_keac374-B1","doi-asserted-by":"crossref","first-page":"e134189","DOI":"10.1172\/jci.insight.134189","article-title":"Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies","volume":"5","author":"Seto","year":"2020","journal-title":"JCI Insight"},{"key":"2023020117310832100_keac374-B2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12967-020-02290-3","article-title":"TLR expression in peripheral monocyte subsets of patients with idiopathic inflammatory myopathies: association with clinical and immunological features","volume":"18","author":"Torres-Ruiz","year":"2020","journal-title":"J Transl Med"},{"key":"2023020117310832100_keac374-B3","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1097\/RHU.0000000000001772","article-title":"Low-density granulocytes and neutrophil extracellular traps as biomarkers of disease activity in adult inflammatory myopathies","volume":"28","author":"Torres-Ruiz","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"2023020117310832100_keac374-B4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00430-010-0151-4","article-title":"Subsets, expansion and activation of myeloid-derived suppressor cells","volume":"199","author":"Ribechini","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"2023020117310832100_keac374-B5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5411\/wji.v4.i1.26","article-title":"Role of myeloid-derived suppressor cells in autoimmune disease","volume":"4","author":"Crook","year":"2014","journal-title":"World J Immunol"},{"key":"2023020117310832100_keac374-B6","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.jid.2016.02.816","article-title":"Myeloid-derived suppressor cells in psoriasis are an expanded population exhibiting diverse T-cell\u2013suppressor mechanisms","volume":"136","author":"Cao","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2023020117310832100_keac374-B7","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"2023020117310832100_keac374-B8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.semarthrit.2015.07.003","article-title":"The potential therapeutic role of myeloid-derived suppressor cells in autoimmune arthritis","volume":"45","author":"Wang","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2023020117310832100_keac374-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2017.10.001","article-title":"Expression of checkpoint molecules on myeloid-derived suppressor cells","volume":"192","author":"Ballbach","year":"2017","journal-title":"Immunol Lett"},{"key":"2023020117310832100_keac374-B10","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/art.39767","article-title":"Myeloid-derived suppressor cells induce the expansion of regulatory B cells and ameliorate autoimmunity in the sanroque mouse model of systemic lupus erythematosus","volume":"68","author":"Park","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2023020117310832100_keac374-B11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00262-018-2277-y","article-title":"MDSCs in infectious diseases: regulation, roles, and readjustment","volume":"68","author":"Dorhoi","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"2023020117310832100_keac374-B12","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1212\/NXI.0000000000000558","article-title":"PD1 pathway in immune-mediated myopathies: pathogenesis of dysfunctional T cells revisited","volume":"6","author":"Knauss","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2023020117310832100_keac374-B13","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.3389\/fimmu.2018.02776","article-title":"The yin and yang of myeloid derived suppressor cells","volume":"9","author":"Budhwar","year":"2018","journal-title":"Front Immunol"},{"key":"2023020117310832100_keac374-B14","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023020117310832100_keac374-B15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome","volume":"23","author":"Witt","year":"2016","journal-title":"Clin Pulm Med"},{"issue":"Suppl 11","key":"2023020117310832100_keac374-B16","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1002\/acr.20532","article-title":"Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023020117310832100_keac374-B17","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/art.21291","article-title":"International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies","volume":"52","author":"Oddis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023020117310832100_keac374-B18","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3892\/mmr.2016.5685","article-title":"Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules","volume":"14","author":"Ilkovitch","year":"2016","journal-title":"Mol Med Rep"},{"key":"2023020117310832100_keac374-B19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1471-2474-15-281","article-title":"Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study","volume":"15","author":"Kurko","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"2023020117310832100_keac374-B20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4049\/jimmunol.1203535","article-title":"Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis","volume":"191","author":"Fujii","year":"2013","journal-title":"J Immunol"},{"key":"2023020117310832100_keac374-B21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009742.2012.716450","article-title":"Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis","volume":"42","author":"Jiao","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"2023020117310832100_keac374-B22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1189\/jlb.4A0314-139R","article-title":"Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease","volume":"97","author":"Crook","year":"2015","journal-title":"J Leukoc Biol"},{"key":"2023020117310832100_keac374-B23","doi-asserted-by":"crossref","first-page":"567783","DOI":"10.3389\/fimmu.2020.567783","article-title":"Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with gout","volume":"11","author":"Zhong","year":"2020","journal-title":"Front Immunol"},{"key":"2023020117310832100_keac374-B24","doi-asserted-by":"crossref","first-page":"331ra40","DOI":"10.1126\/scitranslmed.aae0482","article-title":"Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus","volume":"8","author":"Wu","year":"2016","journal-title":"Sci Transl Med"},{"key":"2023020117310832100_keac374-B25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.molimm.2018.07.016","article-title":"Myeloid-derived suppressor cells exacerbate Sjogren\u2019s syndrome by inhibiting Th2 immune responses","volume":"101","author":"Qi","year":"2018","journal-title":"Mol Immunol"},{"key":"2023020117310832100_keac374-B26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2023020117310832100_keac374-B27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/art.39441","article-title":"Elimination of granulocytic myeloid-derived suppressor cells in lupus-prone mice linked to reactive oxygen species-dependent extracellular trap formation","volume":"68","author":"Vlachou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2023020117310832100_keac374-B28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/annrheumdis-2014-205508","article-title":"Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis","volume":"75","author":"Guo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023020117310832100_keac374-B29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/sji.12473","article-title":"Myeloid-derived suppressor cells in cancers and inflammatory diseases: angel or demon?","volume":"84","author":"Su","year":"2016","journal-title":"Scand J Immunol"},{"key":"2023020117310832100_keac374-B30","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1007\/s11357-014-9729-x","article-title":"Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease","volume":"36","author":"Bueno","year":"2014","journal-title":"Age (Dordr)"},{"key":"2023020117310832100_keac374-B31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.humimm.2016.05.024","article-title":"Myeloid derived suppressor cells and autoimmunity","volume":"77","author":"Boros","year":"2016","journal-title":"Hum Immunol"},{"key":"2023020117310832100_keac374-B32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1183\/13993003.01826-2015","article-title":"Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis","volume":"48","author":"Fernandez","year":"2016","journal-title":"Eur Respir J"},{"key":"2023020117310832100_keac374-B33","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.21037\/jtd.2018.11.16","article-title":"Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study","volume":"10","author":"Jovanovic","year":"2018","journal-title":"J Thorac Dis"},{"key":"2023020117310832100_keac374-B34","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/all.13136","article-title":"Programmed cell death-1 expression correlates with disease severity and IL-5 in chronic rhinosinusitis with nasal polyps","volume":"72","author":"Kortekaas Krohn","year":"2017","journal-title":"Allergy"},{"key":"2023020117310832100_keac374-B35","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","article-title":"Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer","volume":"68","author":"Lin","year":"2019","journal-title":"Gut"},{"key":"2023020117310832100_keac374-B36","doi-asserted-by":"crossref","first-page":"e000285","DOI":"10.1136\/jitc-2019-000285","article-title":"IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2023020117310832100_keac374-B37","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1136\/gutjnl-2016-313075","article-title":"Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway","volume":"66","author":"Wang","year":"2017","journal-title":"Gut"},{"key":"2023020117310832100_keac374-B38","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00330-021-08173-5","article-title":"Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase","volume":"32","author":"Tang","year":"2022","journal-title":"Eur Radiol"},{"key":"2023020117310832100_keac374-B39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s40425-019-0770-2","article-title":"Mechanisms regulating PD-L1 expression on tumor and immune cells","volume":"7","author":"Chen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2023020117310832100_keac374-B40","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent Mycobacterium tuberculosis infection suppresses T-cell function","volume":"188","author":"du Plessis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2023020117310832100_keac374-B41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.201606-1143OC","article-title":"Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis","volume":"196","author":"Uhel","year":"2017","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac374\/45095801\/keac374.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/775\/49031506\/keac374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/775\/49031506\/keac374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:41:43Z","timestamp":1675298503000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/2\/775\/6619574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,29]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac374","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,6,29]]}}}